MNPR
Monopar Therapeutics Inc
79.60$
+1.6%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +40.6% | +37.4% | +133.0% | +4,611.9% | -97.9% | +47.8% | +7.8% | -38.4% | +71.6% | +60.4% | -60.6% | -33.2% | +165.5% | -41.0% | +141.7% | +50.9% | +30.0% | -26.1% | +22.3% | +23.8% | +8.5% | -15.4% | +23.9% | -16.7% | +21.4% | -21.4% | -3.5% | -17.4% | -21.3% | -6.7% | +17.1% | -13.0% | +908.3% | -83.4% | +5.3% | +49.7% | +52.2% | -11.5% | +36.7% | – | |
| – | +75.7% | +7.0% | +18.0% | -24.0% | +98.6% | +3.0% | -21.1% | +4.7% | +31.1% | +19.9% | +5.4% | -10.5% | +18.8% | +23.5% | -20.2% | -37.9% | +60.3% | +9.5% | -10.5% | +0.4% | +19.7% | +5.3% | -12.1% | -1.4% | +19.4% | +8.1% | -15.9% | +2.2% | +16.9% | -13.6% | -13.1% | -10.2% | +94.7% | +37.3% | -4.7% | -0.1% | +47.3% | +78,396.2% | -99.9% | – | |
| – | +63.4% | +16.2% | +59.1% | +2,404.0% | -95.1% | +21.8% | -6.4% | -20.5% | +49.5% | +41.0% | -33.8% | -18.5% | +61.3% | -7.3% | +28.9% | +12.6% | +37.2% | -16.2% | +10.4% | +17.5% | +9.0% | -8.4% | +12.5% | -12.9% | +20.8% | -13.2% | -7.8% | -11.3% | -7.5% | -9.9% | +3.8% | -12.0% | +603.2% | -70.9% | +0.4% | +26.6% | +50.4% | -15.1% | +27.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +280.8% | +485.3% | +12.7% | -9.9% | -8.9% | +43.5% | +31.3% | -13.4% | -15.0% | -11.5% | -22.8% | +150.3% | -59.4% | -53.4% | +15.9% | +8.0% | +14.3% | -95.3% | -9.0% | -11.6% | -10.1% | +1,746.0% | +11.4% | +954.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -69.4% | -32,650.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12.4% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -48.0% | -19,289.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9.0% | -468,047.0% | – | – | – | -19,330.3% | – | – | – | -1,773.5% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.